ATE77750T1 - Antisaeurezusammensetzung. - Google Patents

Antisaeurezusammensetzung.

Info

Publication number
ATE77750T1
ATE77750T1 AT85902269T AT85902269T ATE77750T1 AT E77750 T1 ATE77750 T1 AT E77750T1 AT 85902269 T AT85902269 T AT 85902269T AT 85902269 T AT85902269 T AT 85902269T AT E77750 T1 ATE77750 T1 AT E77750T1
Authority
AT
Austria
Prior art keywords
acid composition
treatment
pharmaceutical composition
composition including
material useful
Prior art date
Application number
AT85902269T
Other languages
English (en)
Inventor
John David Buehler
Joseph Raymond Luber
Wayne Martin Grim
Original Assignee
Rhone Poulenc Rorer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Int filed Critical Rhone Poulenc Rorer Int
Application granted granted Critical
Publication of ATE77750T1 publication Critical patent/ATE77750T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT85902269T 1984-04-19 1985-04-11 Antisaeurezusammensetzung. ATE77750T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60179684A 1984-04-19 1984-04-19
PCT/US1985/000652 WO1985004806A1 (en) 1984-04-19 1985-04-11 Antacid composition
EP85902269A EP0179858B1 (de) 1984-04-19 1985-04-11 Antisäurezusammensetzung

Publications (1)

Publication Number Publication Date
ATE77750T1 true ATE77750T1 (de) 1992-07-15

Family

ID=24408805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85902269T ATE77750T1 (de) 1984-04-19 1985-04-11 Antisaeurezusammensetzung.

Country Status (11)

Country Link
EP (1) EP0179858B1 (de)
JP (1) JPH0764737B2 (de)
KR (1) KR850007561A (de)
CN (1) CN85104754A (de)
AT (1) ATE77750T1 (de)
AU (1) AU578690B2 (de)
CA (1) CA1259916A (de)
DE (1) DE3586281T2 (de)
ES (1) ES8706029A1 (de)
FR (1) FR2563108B1 (de)
WO (1) WO1985004806A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
DE3612086A1 (de) * 1986-04-10 1987-10-15 Bayer Ag Konservierte antacida-zubereitungen
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
US5360793A (en) * 1993-05-24 1994-11-01 Sterling Winthrop Inc. Rafting antacid formulation
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
AU728423B2 (en) * 1996-10-04 2001-01-11 Mcneil-Ppc, Inc. Methods and compositions for preventing and treating heartburn
KR20010020438A (ko) * 1997-04-30 2001-03-15 데일 마틴 주입가능한 알기네이트 조성물
WO2003043641A1 (en) * 2001-11-19 2003-05-30 Nobel Ilaç Sanayii Ve Ticaret A.S. New pharmaceutical combinations prepared with alginates and biphosphonates in order to prevent gastroesophageal reflux during use of oral biphoshonates
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
DE102006037298A1 (de) 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
IT1406155B1 (it) * 2011-02-22 2014-02-14 Rossi Composizioni di alginato di magnesio e derivati come adiuvanti nel trattamento del reflusso gastrico
EA025430B1 (ru) 2012-01-27 2016-12-30 Государственное Научное Учреждение "Институт Биоорганической Химии Национальной Академии Наук Беларуси" Фармацевтическая композиция в качестве субстанции антирефлюксного антацидного препарата
CN104688765A (zh) * 2013-12-04 2015-06-10 博晖(大连)实业有限公司 一种由海藻酸盐组合的组方胃药
IT202100000059A1 (it) * 2021-01-04 2022-07-04 Nyuma Pharma Srl Nuove composizioni di sucralfato in alginato e loro utilizzo in terapia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1363399A (en) * 1972-04-13 1974-08-14 Rotta Research Lab Method of preparing an antacid pharmaceutical product
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
GB1598375A (en) * 1978-02-17 1981-09-16 Anphar Sa Aluminium magnesium carbonate

Also Published As

Publication number Publication date
EP0179858B1 (de) 1992-07-01
WO1985004806A1 (en) 1985-11-07
JPS61501916A (ja) 1986-09-04
EP0179858A1 (de) 1986-05-07
FR2563108B1 (fr) 1987-09-04
DE3586281D1 (de) 1992-08-06
AU578690B2 (en) 1988-11-03
EP0179858A4 (de) 1986-09-15
CN85104754A (zh) 1986-12-10
CA1259916A (en) 1989-09-26
KR850007561A (ko) 1985-12-07
ES542430A0 (es) 1987-06-01
DE3586281T2 (de) 1992-12-10
ES8706029A1 (es) 1987-06-01
JPH0764737B2 (ja) 1995-07-12
FR2563108A1 (fr) 1985-10-25
AU4233685A (en) 1985-11-15

Similar Documents

Publication Publication Date Title
DE3586281D1 (de) Antisaeurezusammensetzung.
NO860362L (no) Keramiske komposittgjenstander og fremgangsmaater for fremstilling derav.
BR8803135A (pt) Composicao consolidavel e material refratario
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
IT1142747B (it) Perfezionamento nelle lime dentali endontiche
NO881270D0 (no) Framgangsmaate for aa redusere carboninnholdet i halvledere.
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
IT1178324B (it) Procedimento e composizione per prevenire la placca dentaria e la gengivite
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
AU1279188A (en) Cement composition and use thereof
DK399985A (da) 6-substituerede mitomycin-analoge, deres anvendelse inden for medicinen og kompositioner indeholdende forbindelserne
DE3885588D1 (de) Photopolymerisierbares Gemisch und daraus hergestelltes Aufzeichnungsmaterial.
DK159088A (da) Overfladebehandlingskompostition
IT1217352B (it) Palizzata in calcestruzzo nonche'procedimento e dispositivo per laproduzione della stessa.
IT8521842A0 (it) Composizione refrattaria eprocedimento per ottenerla.
DE68907680T2 (de) Tonzusammensetzung und Giessverfahren.
KR900700580A (ko) 석탄 슬러리 조성물 및 처리
DK265288A (da) Oximino-ether-forbindelser og fremgangsmaade til fremstilling deraf
JPS56140923A (en) Nutrient composition and administration thereof
DK97587A (da) Vasopressinforbindelser og fremgangsmaade til fremstilling deraf
IT1164867B (it) Composizione dentaria e relativa amalgama
KR880019435U (ko) 프레스기의 u-벤딩과 z-벤딩의 복합금형장치
NO890097D0 (no) Liposom/doksorubicin-sammensetning og fremgangsmaate.
EP0278715A3 (de) Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen
ES2008576A6 (es) Metodo de fabricacion de feretros.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time